Archive




Volume 9, Issue 3, May 2020, Page: 21-36
Modelling Time to Mortality with Congestive Heart Failure: A Case Study in Wollo General and Referral Government Hospitals
Habtamu Dessie, Department of Statistics, Faculty of Natural and Computational Science, Woldia University, Woldia, Ethiopia
Yenefenta Wube, Department of Statistics, Faculty of Natural and Computational Science, Woldia University, Woldia, Ethiopia
Belete Adelo, Department of Statistics, Faculty of Natural and Computational Science, Woldia University, Woldia, Ethiopia
Eskeziaw Abebe, Department of Midwifery, Faculty of Natural and Computational Science, Woldia University, Woldia, Ethiopia
Received: Oct. 7, 2019;       Accepted: Apr. 16, 2020;       Published: Apr. 28, 2020
DOI: 10.11648/j.ajtas.20200903.11      View  54      Downloads  25
Abstract
Congestive heart failure is a complex clinical syndrome of functional or structural impairment in the heart. Nowadays heart failure is common and increasing in the world and researches on this area is limited. Therefore the aim of the present study was to analyze and quantify the impact of modelling heart failure survival allowing for covariates with time varying effects known to be independent predictors of overall mortality in this clinical setting. A retrospective cohort study was conducted on CHF patients who were on treatment follow up at both WGH and DRH from January 1, 2010 to December 30, 2016. A total of 487 patients were selected by using simple random sampling from the patient's medical record. Semi parametric, parametric PH models and AFT models was employed to identify the best model which shown as the real causation of factors with the outcome of CHF which is death. The Weibull accelerated failure time model result showed that the risk factors related to accelerating or decelerating the lifespan were age (TR=0.962, p=0.000), Residence (rural) (TR=1.24, p=0.019), Nutritional (Poor) (TR=0.582, p=0.000), Smoking (TR=0.774, p=0.005), Alcoholism (TR=1.394, p=0.010), Diabetes mellitus (TR=0.49, p=0.000), Hypertension (TR=0.079, p=0.019), Stroke (TR=0.799, p=0.014), Coronary Artery disease (TR=0.276, p=0.012), Tuberculosis bacillus (TR=0.103, p=0.000) as a co morbidity and the interaction between age and Tuberculosis bacillus (p=0.000), age and Coronary artery disease (p=0.041), Diabetes mellitus with Hypertension (p=0.000), Hypertension with Nutritional status (p=0.000) and age with time (p=0.000) were found statistically significant. The Weibull accelerated failure time model performed better explain the effect of predictors than other Cox and parametric PH models. Thus, researchers should use parametric AFT models to see regression varying effect covariates. Frequent monitoring and follow up of Patients with heart failure should be adopted.
Keywords
CHF, Retrospective Cohort Study, Parametric AFT Model, Censoring, Mortality
To cite this article
Habtamu Dessie, Yenefenta Wube, Belete Adelo, Eskeziaw Abebe, Modelling Time to Mortality with Congestive Heart Failure: A Case Study in Wollo General and Referral Government Hospitals, American Journal of Theoretical and Applied Statistics. Vol. 9, No. 3, 2020, pp. 21-36. doi: 10.11648/j.ajtas.20200903.11
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Agvall. (2014). Heart failure in primar care with specia lemphasis on costs and benefits of a disease management program. Sweden PhD dissertation, Linköping University.
[2]
Ponikowski, P. A. (2014). Heart failure: Preventing disease and death worldwide. European Society of Cardiology; from: http://spo.escardio.org/eslides/view.aspx?eevtid=59&f, Available.
[3]
Owusu, I. B. (2013). Prevalence and etiology of Heart Failure in Patients SeenataTeaching Hospital in Ghana. J Cardiovasc Dis Diagn, 1: 131.
[4]
Tantchou, Tchoumi, Jacques, Cabraletal.(2011). Retrieved from The Pan African Medical Journal - ISSN 1937-8688.: http://www.panafrican-med-journal.com/content/article/8/11/full/.
[5]
Cabral, T. S. (2011). Occurrence, etiology and challenges in the management of congestive heart failure in sub-Saharan Africa: experience of the Cardiac Centrein Shisong, Cameroon. Pan African Medical journal, 8: 11.
[6]
Misganaw, A. H. -M. -M. (2014). Epidemiology of Major Non-communicable Diseases in Ethiopia. A Systematic Review. J Health Popul Nutr 32 (1), 1-13.
[7]
Misganaw, A. H. -M. (2012). The Double Mortality Burden among Adults in Addis Ababa, Ethiopia, 2006-2009. Prev Chronic Dis, 9: 110-142.
[8]
Azmera, h. (2015). Survival during Treatment Period of Patients with Severe Heart Failure Admitted to Intensive Care Unit (ICU) at Gondar University Hospital. American journal of health research, 257-269.
[9]
Bennett, D. E. (2012). Study protocol: systematic review of the burden of heart failure in low-and middle-income countries. Bennettetat. Systematic reviews, 1: 59.
[10]
Cook, C. C. (2013). The annual global economic burden of heart failure. Int J Cardiol: available from: http: //dx. doi. org/10. 1016/j. ijcard. 2013. 12. 028.
[11]
KhalilMurad, M. a. (2012). Frailty and Multiple Comorbidities in the Elderly Patient with Heart Failure: Implications for Management. Heart Fail Rev: doi: 10. 1007/s10741-011-9258-y, 581–588.
[12]
Aalen, o. (1989). A linear regression model for the analysis of life times. Statist. Med., 8: 907–925.
[13]
Cox, D. (1972). Regression models and life-tables. Journal of the Royal Statistical Society Series B (Methodological), 34 (2): 187-220.
[14]
Capell, E. F., Colet, J. C., Miralles, J. D., Saladich, I. J., Wensing, M., Rotellar, J. M. (2013). Survival in Mediterranean Ambulatory Patients With Chronic Heart Failure. A Population-based Study. Rev Esp Cardiol 66 (7): 539–544.
[15]
GioloSR, K. J. (2012). Survival Analysis of Patients with Heart Failure: Implications of Time-Varying Regression Effects in Modeling Mortality. PLoS ONE7.
[16]
Retrieved from http://Chronic kidney disease and heart failure Bidirectional close link and common the rapeuticgoal Science Direct.html.
[17]
BadveSV, RobertsMA, HawleyCM, CassA, GargAX, KrumH, TonkinA, PerkovicV.. (2011). Effects of beta adrenergic antagonists in patients with chronic kidney disease: asystematicreviewandmeta-analysis. J Am Coll Cardiol, 1152–1161.
[18]
Akiomiyoshisha, y. k. (2017). The impact of nutration indices on mortality inpatients with heart failur. Open heart. bmj.(6): e37392. doi: 10. 1371/journal. pone. 0037392.
[19]
Clare J Taylor, Ronan Ryan, Linda Nichols, Nicola Gale, FD Richard Hobbs, and Tom Marshall (2017). Survival following a diagnosis of heart failure in primary care. Family Practice, Vol. 34, No. 2, 161–168.
[20]
Mulubirhan Tirfe, Teshome Nedi, Desalew Mekonnen and Alemseged Beyene (2020). Treatment outcome and its predictors among patients of acute heart failure at a tertiary care hospital in Ethiopia: a prospective observational study. BMC Cardio vascular Disorders 20: 16.
[21]
Saifullah Nasir, M. a (2012). Congestive Heart Failure and Diabetes: Balancing Glycemic Control with Heart Failure Improvement. Winter Center for Heart Failure Research and section of Cardiology; Am J, 110.
Browse journals by subject